Prognostic Significance of Small Troponin I Rise After a Successful Elective Percutaneous Coronary Intervention of a Native Artery

American Journal of Cardiology

Volumn 103, Issue 5, 2009, Pages 639-645

  De Labriolle, Axel ^a   Lemesle, Gilles ^a   Bonello, Laurent ^a   Syed, Asmir I ^a   Collins, Sara D ^a   Ben Dor, Itsik ^a   Pinto Slottow, Tina L ^a   Xue, Zhenyi ^a   Torguson, Rebecca ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Pichard, Augusto D ^a   Lindsay, Joseph ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TROPONIN I;

EID: 60249102378     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.10.044     Document Type: Article

References (20)

1. Thygesen K., Alpert J.S., White H.D., and Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
2. Prasad A., Singh M., Lerman A., Lennon R.J., Holmes Jr. D.R., and Rihal C.S. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol 48 (2006) 1765-1770
3. Kizer J.R., Muttrej M.R., Matthai W.H., McConnell J., Nardone H., Sonel A.F., Keane M.G., and Wilensky R.L. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J 24 (2003) 1314-1322
4. Ricciardi M.J., Davidson C.J., Gubernikoff G., Beohar N., Eckman L.J., Parker M.A., and Bonow R.O. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 145 (2003) 522-528
5. Nallamothu B.K., Chetcuti S., Mukherjee D., Grossman P.M., Kline-Rogers E., Werns S.W., Bates E.R., and Moscucci M. Prognostic implication of troponin I elevation after percutaneous coronary intervention. Am J Cardiol 91 (2003) 1272-1274
6. Cantor W.J., Newby L.K., Christenson R.H., Tuttle R.H., Hasselblad V., Armstrong P.W., Moliterno D.J., Califf R.M., Topol E.J., Ohman E.M., and SYMPHONY and 2nd SYMPHONY Cardiac Markers Substudy Investigators. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 39 (2002) 1738-1744
7. Kini A.S., Lee P., Marmur J.D., Agarwal A., Duffy M.E., Kim M.C., and Sharma S.K. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol 93 (2004) 18-23
8. Natarajan M.K., Kreatsoulas C., Velianou J.L., Mehta S.R., Pericak D., and Goodhart D.M. Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions. Am J Cardiol 93 (2004) 750-753
9. Bertinchant J.P., Polge A., Ledermann B., Genet L., Fabbro-Peray P., Raczka F., Brunet J., Poirey S., Wittenberg O., Pernel I., and Nigond J. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 84 (1999) 51-57
10. Garbarz E., Iung B., Lefevre G., Makita Y., Farah B., Michaud P., Graine H., and Vahanian A. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol 84 (1999) 515-518
11. Saadeddin S.M., Habbab M.A., Sobki S.H., and Ferns G.A. Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome. Ann Clin Biochem 39 pt 4 (2002) 392-397
12. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., Morrison D.A., O'Neil W.W., Schaff H.V., Whitlow P.L., et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113 suppl (2006) e166-e286
13. Antman E.M. Decision making with cardiac troponin tests. N Engl J Med 346 (2002) 2079-2082
14. Cavallini C., Savonitto S., Violini R., Arraiz G., Plebani M., Olivari Z., Rubartelli P., Battaglia S., Niccoli L., Steffenino G., Ardissino D., Italian Atherosclerosis, Thrombosis, and and Vascular Biology and Society for Invasive Cardiology-GISE Investigators. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J 26 (2005) 1494-1498
15. Nienhuis M.B., Ottervanger J.P., Bilo H.J., Dikkeschei B.D., and Zijlstra F. Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv 71 (2008) 318-324
16. Nageh T., Sherwood R.A., Harris B.M., and Thomas M.R. Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease. Heart 91 (2005) 1181-1185
17. Stone G.W., Mehran R., Dangas G., Lansky A.J., Kornowski R., and Leon M.B. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation 104 (2001) 642-647
18. Costa T.N., Cassaro Strunz C.M., Nicolau J.C., and Gutierrez P.S. Comparison of MB fraction of creatine kinase mass and troponin I serum levels with necropsy findings in acute myocardial infarction. Am J Cardiol 101 (2008) 311-314
19. Selvanayagam J.B., Porto I., Channon K., Petersen S.E., Francis J.M., Neubauer S., and Banning A.P. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 111 (2005) 1027-1032
20. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., Neumann F.J., Robertson D.H., DeLucca P.T., DiBattiste P.M., Gibson C.M., Braunwald E., and TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344 (2001) 1879-1887